Latest News about INM
Recent news which mentions INM
InMed Pharmaceuticals Is Commercializing The Development Of Rare Cannabinoids For The Wellness Market
May 17, 2022
Tickers
INM
From Benzinga
InMed Pharmaceuticals Reports Net Sales Of $575K For 6 Months Since BayMedica Acquisition
May 13, 2022
Tickers
INM
From Benzinga
From Benzinga
From InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
May 03, 2022
From Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
From Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
From Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Announces Expansion Of Rare Cannabinoid Portfolio
April 22, 2022
Tickers
INM
From Benzinga
63 Biggest Movers From Yesterday
March 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
From Benzinga
InMed's Evolution To Commercial Sales Featured In Research Report
February 17, 2022
Tickers
INM
From Benzinga
InMed Names BayMedica VP Of Sales, Releases Q2 2022 Report
February 16, 2022
Tickers
INM
From Benzinga
InMed Positioned To Offer Rare Cannabinoid Manufacturing Technologies
February 15, 2022
Tickers
INM
From Benzinga
InMed Pharmaceuticals To Release Q2 Financial Report, Update
February 11, 2022
Tickers
INM
From Benzinga
4 Penny Stocks Insiders Are Buying
January 07, 2022
From Benzinga
InMed Pharmaceuticals to Present at Tribe Public's Webinar Event
December 30, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals Announces Publication of Article on CBN as Possible Glaucoma Treatment
December 20, 2021
Tickers
INM
From Benzinga
InMed Pharmaceuticals' Study Marks First Phase 2 Trial to Evaluate Cannabinol for Disease Treatment
December 10, 2021
Tickers
INM
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.